How This Biotech Company Secured More Than $275 Million From Investors, Twice



Element Biosciences raised more than $277 million for its Series D–just $1 million more than its Series C.

Speak Your Mind

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get in Touch

350FansLike
100FollowersFollow
281FollowersFollow
150FollowersFollow

Recommend for You

Oh hi there 👋
It’s nice to meet you.

Subscribe and receive our weekly newsletter packed with awesome articles that really matters to you!

We don’t spam! Read our privacy policy for more info.

You might also like

How To Identify Your Startup Early Adopters

Understanding and clearly defining your early adopters bring you...

How technology is redrawing the boundaries of the firm

Technology and business are inextricably linked. Entrepreneurs harness technological advances and, with skill and...

Stocks Rise As U.S.-China Phone Calls Boosts Optimism, Euro...

NEW YORK: The euro rose on better-than-expected German business morale data on Tuesday while...

Soltau And Team Taking $10 Million In Bonuses Out...

Penney may be about to file bankruptcy but don't...